As Novo Nordisk’s patent expires on March 20, Sun Pharma, Dr Reddy’s, Zydus and Mankind enter the market after months of ...

GLP-1 medications work by mimicking glucagon-like peptide-1, a hormone released from the gut after eating, which regulates ...

GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression ...

GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, ...

People regain weight after stopping the injections since the medication suppresses appetite and increases feelings of ...

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, ...

SCHOOL CARE SAYS THE COST OF HEALTH CARE IS UP NATIONWIDE. AND HERE IN NEW HAMPSHIRE, THE NONPROFIT SAW A RISE IN CLAIMS ...

Ingredient giant Ingredion has partnered with AI protein discovery platform Shiru to commercialise next-gen prebiotics for ...

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other ...

A Webb City woman experienced severe illness after accidentally overdosing on GLP-1 medication, which she hopes will serve as ...

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.